Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.
Benítez JA, García L, Silva A, García H, Fando R, Cedré B, Pérez A, Campos J, Rodríguez BL, Pérez JL, Valmaseda T, Pérez O, Pérez A, Ramírez M, Ledón T, Jidy MD, Lastre M, Bravo L, Sierra G.
Benítez JA, et al. Among authors: perez jl, perez o, perez a.
Infect Immun. 1999 Feb;67(2):539-45. doi: 10.1128/IAI.67.2.539-545.1999.
Infect Immun. 1999.
PMID: 9916056
Free PMC article.
Clinical Trial.